Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tension-Type Headache | 21 | 2024 | 76 | 8.220 |
Why?
|
Migraine Disorders | 37 | 2024 | 1713 | 6.430 |
Why?
|
Headache Disorders | 8 | 2024 | 152 | 2.400 |
Why?
|
Headache | 22 | 2024 | 1264 | 2.330 |
Why?
|
Neck Pain | 6 | 2024 | 191 | 1.790 |
Why?
|
Pain Threshold | 11 | 2023 | 606 | 1.470 |
Why?
|
Trigeminal Neuralgia | 2 | 2024 | 105 | 1.220 |
Why?
|
Post-Traumatic Headache | 7 | 2023 | 69 | 1.200 |
Why?
|
Hyperalgesia | 4 | 2023 | 527 | 0.940 |
Why?
|
Headache Disorders, Secondary | 2 | 2024 | 34 | 0.880 |
Why?
|
Tooth Loss | 1 | 2024 | 200 | 0.790 |
Why?
|
Pain Measurement | 6 | 2024 | 3586 | 0.730 |
Why?
|
Calcitonin Gene-Related Peptide | 3 | 2020 | 328 | 0.730 |
Why?
|
Analgesics | 7 | 2024 | 1071 | 0.690 |
Why?
|
Vertigo | 1 | 2020 | 205 | 0.610 |
Why?
|
Disability Evaluation | 2 | 2024 | 1839 | 0.590 |
Why?
|
Pain Perception | 2 | 2017 | 198 | 0.570 |
Why?
|
Central Nervous System Agents | 1 | 2017 | 73 | 0.560 |
Why?
|
Cluster Headache | 1 | 2017 | 54 | 0.550 |
Why?
|
Dizziness | 1 | 2020 | 269 | 0.550 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1738 | 0.540 |
Why?
|
Pain, Intractable | 1 | 2016 | 132 | 0.510 |
Why?
|
Cost of Illness | 2 | 2024 | 1960 | 0.500 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2016 | 451 | 0.460 |
Why?
|
Botulinum Toxins, Type A | 3 | 2022 | 238 | 0.430 |
Why?
|
Health Status Disparities | 1 | 2024 | 1886 | 0.420 |
Why?
|
Sensory System Agents | 1 | 2012 | 24 | 0.410 |
Why?
|
Cortical Spreading Depression | 3 | 2021 | 288 | 0.400 |
Why?
|
Neuralgia, Postherpetic | 1 | 2012 | 41 | 0.400 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2020 | 4640 | 0.390 |
Why?
|
Wounds and Injuries | 1 | 2024 | 2517 | 0.390 |
Why?
|
Capsaicin | 1 | 2012 | 235 | 0.370 |
Why?
|
Depressive Disorder, Major | 2 | 2021 | 4818 | 0.370 |
Why?
|
International Classification of Diseases | 1 | 2016 | 936 | 0.360 |
Why?
|
Ketamine | 1 | 2016 | 527 | 0.350 |
Why?
|
Epilepsy | 2 | 2023 | 3326 | 0.350 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3235 | 0.340 |
Why?
|
Tryptamines | 4 | 2024 | 93 | 0.330 |
Why?
|
Brain Concussion | 4 | 2022 | 1436 | 0.330 |
Why?
|
Humans | 81 | 2024 | 768970 | 0.330 |
Why?
|
Low Back Pain | 1 | 2018 | 990 | 0.320 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2010 | 131 | 0.310 |
Why?
|
Spinal Puncture | 1 | 2010 | 286 | 0.300 |
Why?
|
Self Report | 3 | 2022 | 3773 | 0.290 |
Why?
|
Quality of Life | 8 | 2024 | 13510 | 0.280 |
Why?
|
Moyamoya Disease | 1 | 2009 | 274 | 0.260 |
Why?
|
Antibodies, Monoclonal | 3 | 2023 | 9264 | 0.260 |
Why?
|
Serotonin Receptor Agonists | 1 | 2006 | 151 | 0.240 |
Why?
|
Amitriptyline | 2 | 2010 | 112 | 0.240 |
Why?
|
Muscle, Skeletal | 5 | 2015 | 4978 | 0.230 |
Why?
|
Nociceptors | 4 | 2021 | 460 | 0.230 |
Why?
|
Comorbidity | 6 | 2024 | 10592 | 0.230 |
Why?
|
Population Surveillance | 1 | 2014 | 2597 | 0.220 |
Why?
|
Adult | 29 | 2024 | 223851 | 0.220 |
Why?
|
Mastocytosis, Systemic | 1 | 2005 | 102 | 0.220 |
Why?
|
Carbamazepine | 1 | 2024 | 224 | 0.220 |
Why?
|
Vascular Headaches | 1 | 2023 | 21 | 0.210 |
Why?
|
Migraine with Aura | 3 | 2023 | 204 | 0.210 |
Why?
|
Female | 34 | 2024 | 397515 | 0.210 |
Why?
|
Serotonin | 2 | 2005 | 1043 | 0.210 |
Why?
|
Vasoconstrictor Agents | 1 | 2006 | 657 | 0.200 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2024 | 219 | 0.200 |
Why?
|
Middle Aged | 24 | 2024 | 223737 | 0.200 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2022 | 42 | 0.200 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26395 | 0.190 |
Why?
|
Migraine without Aura | 2 | 2013 | 82 | 0.180 |
Why?
|
Regenerative Medicine | 1 | 2024 | 311 | 0.180 |
Why?
|
Chronic Disease | 7 | 2024 | 9384 | 0.180 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2004 | 371 | 0.180 |
Why?
|
Whiplash Injuries | 1 | 2020 | 15 | 0.180 |
Why?
|
Nausea | 1 | 2023 | 682 | 0.170 |
Why?
|
Treatment Outcome | 12 | 2024 | 65480 | 0.170 |
Why?
|
Intracranial Hypotension | 2 | 2010 | 42 | 0.170 |
Why?
|
Prevalence | 8 | 2023 | 15879 | 0.170 |
Why?
|
Exosomes | 1 | 2024 | 429 | 0.170 |
Why?
|
Depressive Disorder | 1 | 2012 | 3723 | 0.170 |
Why?
|
Male | 27 | 2024 | 365203 | 0.170 |
Why?
|
Electric Stimulation Therapy | 2 | 2024 | 637 | 0.160 |
Why?
|
Double-Blind Method | 6 | 2024 | 12467 | 0.160 |
Why?
|
Comprehension | 1 | 2024 | 639 | 0.150 |
Why?
|
Vagus Nerve Stimulation | 1 | 2022 | 229 | 0.150 |
Why?
|
Headache Disorders, Primary | 1 | 2018 | 39 | 0.150 |
Why?
|
Meninges | 1 | 2019 | 197 | 0.150 |
Why?
|
Neuromuscular Agents | 1 | 2019 | 148 | 0.150 |
Why?
|
Life Expectancy | 1 | 2024 | 1249 | 0.150 |
Why?
|
Aged | 11 | 2024 | 171786 | 0.140 |
Why?
|
Risk Factors | 10 | 2024 | 74976 | 0.130 |
Why?
|
United States | 7 | 2024 | 73186 | 0.130 |
Why?
|
Middle Cerebral Artery | 1 | 2017 | 273 | 0.130 |
Why?
|
Neuralgia | 1 | 2022 | 622 | 0.130 |
Why?
|
Adolescent | 8 | 2024 | 89244 | 0.120 |
Why?
|
Societies, Medical | 2 | 2024 | 3968 | 0.120 |
Why?
|
Longitudinal Studies | 4 | 2022 | 14794 | 0.120 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2019 | 2276 | 0.120 |
Why?
|
Young Adult | 5 | 2024 | 60131 | 0.120 |
Why?
|
Pain | 4 | 2022 | 5100 | 0.110 |
Why?
|
Relaxation Therapy | 1 | 2015 | 181 | 0.110 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1076 | 0.110 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 1376 | 0.110 |
Why?
|
Mortality | 1 | 2024 | 2914 | 0.110 |
Why?
|
Skin | 2 | 2008 | 4506 | 0.100 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2231 | 0.100 |
Why?
|
Brain Infarction | 1 | 2013 | 288 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2022 | 3628 | 0.090 |
Why?
|
Geriatric Assessment | 1 | 2018 | 1422 | 0.090 |
Why?
|
Cerebrospinal Fluid Pressure | 1 | 2010 | 38 | 0.090 |
Why?
|
Subarachnoid Space | 1 | 2010 | 79 | 0.090 |
Why?
|
Leukoencephalopathies | 1 | 2013 | 260 | 0.090 |
Why?
|
Administration, Topical | 1 | 2012 | 704 | 0.090 |
Why?
|
Prospective Studies | 4 | 2023 | 54962 | 0.090 |
Why?
|
Post-Dural Puncture Headache | 1 | 2010 | 53 | 0.080 |
Why?
|
Photophobia | 1 | 2009 | 77 | 0.080 |
Why?
|
Electric Stimulation | 2 | 2005 | 1742 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2931 | 0.080 |
Why?
|
Child | 4 | 2024 | 80960 | 0.080 |
Why?
|
Health Policy | 1 | 2021 | 2700 | 0.080 |
Why?
|
Biomedical Research | 1 | 2023 | 3463 | 0.070 |
Why?
|
Incidence | 2 | 2023 | 21547 | 0.070 |
Why?
|
Mianserin | 1 | 2007 | 51 | 0.070 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2010 | 227 | 0.070 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2007 | 173 | 0.070 |
Why?
|
Cohort Studies | 4 | 2023 | 41808 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3110 | 0.070 |
Why?
|
Self Medication | 1 | 2006 | 115 | 0.060 |
Why?
|
Ibuprofen | 1 | 2007 | 229 | 0.060 |
Why?
|
Myofascial Pain Syndromes | 1 | 2005 | 37 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 3 | 2021 | 8144 | 0.060 |
Why?
|
Infant, Newborn | 1 | 2024 | 26428 | 0.060 |
Why?
|
Severity of Illness Index | 4 | 2012 | 15951 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4748 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2009 | 1272 | 0.060 |
Why?
|
Spinal Nerves | 1 | 2024 | 92 | 0.060 |
Why?
|
Denmark | 1 | 2006 | 776 | 0.060 |
Why?
|
Physical Stimulation | 1 | 2005 | 517 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 13021 | 0.050 |
Why?
|
Infant | 1 | 2024 | 36556 | 0.050 |
Why?
|
Taiwan | 1 | 2023 | 524 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9756 | 0.050 |
Why?
|
Child, Preschool | 1 | 2024 | 42683 | 0.050 |
Why?
|
Disabled Persons | 2 | 2022 | 1210 | 0.050 |
Why?
|
Citalopram | 1 | 2004 | 401 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7478 | 0.040 |
Why?
|
Logistic Models | 2 | 2012 | 13318 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10400 | 0.040 |
Why?
|
Leg | 1 | 2005 | 1089 | 0.040 |
Why?
|
Neuropeptides | 1 | 2005 | 951 | 0.040 |
Why?
|
Rats | 3 | 2021 | 23786 | 0.040 |
Why?
|
Drug Combinations | 1 | 2006 | 2089 | 0.040 |
Why?
|
Ketorolac | 1 | 2020 | 95 | 0.040 |
Why?
|
Head | 1 | 2005 | 927 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59739 | 0.040 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2019 | 98 | 0.040 |
Why?
|
Rodentia | 1 | 2020 | 262 | 0.040 |
Why?
|
Dilatation | 1 | 2020 | 313 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 15471 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2019 | 81903 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2003 | 2932 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 2862 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7460 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2108 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2007 | 6320 | 0.040 |
Why?
|
Animals | 5 | 2024 | 169335 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 556 | 0.030 |
Why?
|
Osteoarthritis | 1 | 2024 | 1070 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2017 | 279 | 0.030 |
Why?
|
Propensity Score | 1 | 2023 | 1968 | 0.030 |
Why?
|
Arteries | 1 | 2020 | 1126 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1036 | 0.030 |
Why?
|
Body Mass Index | 1 | 2012 | 13055 | 0.030 |
Why?
|
Forecasting | 1 | 2003 | 2945 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36854 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 1 | 2024 | 1672 | 0.030 |
Why?
|
Blood Platelets | 1 | 2004 | 2479 | 0.030 |
Why?
|
Nerve Block | 1 | 2020 | 716 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39394 | 0.030 |
Why?
|
Dexamethasone | 1 | 2020 | 1965 | 0.030 |
Why?
|
Prognosis | 3 | 2010 | 30046 | 0.020 |
Why?
|
Piperidines | 1 | 2020 | 1667 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8748 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1767 | 0.020 |
Why?
|
Gene Expression | 1 | 2022 | 7603 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12562 | 0.020 |
Why?
|
Developing Countries | 1 | 2021 | 2911 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3904 | 0.020 |
Why?
|
Nitric Oxide Synthase | 1 | 2010 | 911 | 0.020 |
Why?
|
Iatrogenic Disease | 1 | 2010 | 552 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8384 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2734 | 0.020 |
Why?
|
Brain | 1 | 2013 | 27453 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3313 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13674 | 0.010 |
Why?
|
Cognition | 1 | 2021 | 7081 | 0.010 |
Why?
|
Random Allocation | 1 | 2008 | 2394 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3838 | 0.010 |
Why?
|
Sensory Receptor Cells | 1 | 2008 | 508 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2008 | 1194 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10868 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16731 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8749 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22379 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10847 | 0.010 |
Why?
|
Treatment Failure | 1 | 2007 | 2664 | 0.010 |
Why?
|
Regression Analysis | 1 | 2008 | 6346 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2714 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10765 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10633 | 0.010 |
Why?
|
Mice | 1 | 2020 | 82072 | 0.010 |
Why?
|
Depression | 1 | 2008 | 8231 | 0.000 |
Why?
|
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_